Identification and pharmacological characterization of the prostaglandin FP receptor and FP receptor variant complexes
about
The Endocannabinoid System as a Therapeutic Target in GlaucomaEndocannabinoid oxygenation by cyclooxygenases, lipoxygenases, and cytochromes P450: cross-talk between the eicosanoid and endocannabinoid signaling pathways(R)-Profens are substrate-selective inhibitors of endocannabinoid oxygenation by COX-2Bimatoprost-loaded ocular inserts as sustained release drug delivery systems for glaucoma treatment: in vitro and in vivo evaluationProstanoid receptor antagonists: development strategies and therapeutic applicationsClinical appraisal of tafluprost in the reduction of elevated intraocular pressure (IOP) in open-angle glaucoma and ocular hypertensionSubstrate-selective COX-2 inhibition as a novel strategy for therapeutic endocannabinoid augmentationBimatoprost in the treatment of eyelash hypotrichosisEffects of prostaglandin analogues on aqueous humor outflow pathways.Comprehensive expression analysis of prostanoid enzymes and receptors in the human endometrium across the menstrual cycleThe impact of timolol maleate on the ocular tolerability of fixed-combination glaucoma therapies.Cellular basis for bimatoprost effects on human conventional outflow.Structural determinants for calcium mobilization by prostaglandin E2 and prostaglandin F2alpha glyceryl esters in RAW 264.7 cells and H1819 cellsFixed-combination treatments for intraocular hypertension in Chinese patients - focus on bimatoprost-timolol.Iris and periocular adverse reactions to bimatoprost in Japanese patients with glaucoma or ocular hypertension.4'-O-methylhonokiol increases levels of 2-arachidonoyl glycerol in mouse brain via selective inhibition of its COX-2-mediated oxygenation.Prostaglandin E2-Glyceryl Ester: In Vivo Evidence for a Distinct Pharmacological Identity from Intraocular Pressure Studies.A randomized crossover study comparing tafluprost 0.0015% with travoprost 0.004% in patients with normal-tension glaucoma [corrected].Putative role of prostaglandin receptor in intracerebral hemorrhage.The prostamide-related glaucoma therapy, bimatoprost, offers a novel approach for treating scalp alopecias.An eicosanoid-centric view of atherothrombotic risk factorsDifferential effects of prostaglandin E2-sensitive receptors on contractility of human ocular cells that regulate conventional outflowAnandamide-derived prostamide F2α negatively regulates adipogenesisProstamide F(2) α receptor antagonism combined with inhibition of FAAH may block the pro-inflammatory mediators formed following selective FAAH inhibitionHuman T lymphoblast cell line expresses FP receptor.The biodisposition and hypertrichotic effects of bimatoprost in mouse skinRole of prostaglandins and specific place in therapy of bimatoprost in the treatment of elevated intraocular pressure and ocular hypertension: A closer look at the agonist properties of bimatoprost and the prostamides.Induction of angiogenic immediate early genes by activation of FP prostanoid receptors in cultured human ciliary smooth muscle cells.Association between genetic polymorphisms of the prostaglandin F2α receptor gene, and response to latanoprost in patients with glaucoma and ocular hypertension.Ocular hypotensive effects of prostaglandin analogs in Japanese patients with normal-tension glaucoma: a literature review
P2860
Q26765508-4B220B1E-266D-4BC6-B065-BA72B5CBDFABQ26823256-ADBA9ACD-C651-4808-B2BF-2CE004BD1183Q27675386-9D4CAB26-5127-4714-8337-380A38202837Q28538289-A6FF68D9-8B5A-4333-B199-B9505058EAC6Q33485483-2D9A057B-3C56-4432-A167-C92FD414483BQ33774236-13140955-E7C3-4AFE-BA2F-FE18F49850FBQ33819279-FAAE352F-EA0E-42A4-823A-CED3AB474155Q33819865-5995E152-7093-44AD-9387-A4068DB37D9AQ34393424-6DB3643A-4616-4D57-8A11-8ED8E3E14348Q34568806-D07BE2BD-4AEF-4B6B-B405-C69B7AACB173Q34731426-3DF4B697-DA64-49E6-B0E7-7CEC903F89F3Q34735244-63B9E06F-7CEE-4BF1-BADF-60D61DEE7981Q35545617-0F76D10A-7C8A-44E3-8E1D-A52EFBE79AB4Q35617544-1077836F-7EC4-4A85-B977-6F81F09BFE1DQ35682058-40C3EC06-7142-4904-A656-F2252739A900Q35814389-A0AA408E-069C-49AD-81C2-6A63311F2A95Q36027609-B79CC6F8-7373-463A-8796-AF51779BF5FDQ36286965-85616452-B8C0-4D26-9A6F-45479D70F450Q36337569-17AC8ED8-5FFC-4A65-97D0-D26CF7CF9446Q36534398-88235B61-A2C5-46DC-9A28-9AB05170323EQ36952174-CC3F27A2-EB4B-4500-A60B-53020D9ACABAQ37035691-CE7CEC77-CAF1-4006-8D0A-B55A38FC0D05Q37095444-A22D0E81-E04C-47A2-AC0A-120C6FEA997BQ38274796-265CF31B-FEE0-4F93-95A8-78C3163F131EQ39539218-7999D056-F11F-4363-942B-EB026A694D55Q41250376-C3DA6917-007D-4281-8E8E-8954D671A429Q42943389-69456F26-C62B-4B9C-B6B9-70AF627EC48EQ43070116-25DEAA08-2CF7-4E36-8561-3BF5D222EA91Q48893703-FFC58FAC-A2BC-4EC1-9E18-792CC611CFEEQ57071071-873FB263-D2C9-4686-9976-BD0381350A4A
P2860
Identification and pharmacological characterization of the prostaglandin FP receptor and FP receptor variant complexes
description
2008 nî lūn-bûn
@nan
2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Identification and pharmacolog ...... FP receptor variant complexes
@ast
Identification and pharmacolog ...... FP receptor variant complexes
@en
Identification and pharmacolog ...... FP receptor variant complexes
@en-gb
Identification and pharmacolog ...... FP receptor variant complexes
@nl
type
label
Identification and pharmacolog ...... FP receptor variant complexes
@ast
Identification and pharmacolog ...... FP receptor variant complexes
@en
Identification and pharmacolog ...... FP receptor variant complexes
@en-gb
Identification and pharmacolog ...... FP receptor variant complexes
@nl
prefLabel
Identification and pharmacolog ...... FP receptor variant complexes
@ast
Identification and pharmacolog ...... FP receptor variant complexes
@en
Identification and pharmacolog ...... FP receptor variant complexes
@en-gb
Identification and pharmacolog ...... FP receptor variant complexes
@nl
P2093
P2860
P921
P356
P1476
Identification and pharmacolog ...... FP receptor variant complexes
@en
P2093
A H-P Krauss
D F Woodward
K Landsverk
P2860
P304
P356
10.1038/BJP.2008.142
P407
P577
2008-07-01T00:00:00Z